Home
|
About us
|
Editorial board
|
Search
|
Ahead of print
|
Current Issue
|
Archives
|
Submit Article
|
Instructions
|
Subscribe
|
Contact us
|
Advertise
|
Login
Users online:10
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2010| January-March | Volume 1 | Issue 1
Online since
February 8, 2010
Archives
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
CLINICAL
Double-blind, placebo-controlled clinical evaluation of an Ayurvedic formulation (GlucoCare capsules) in non-insulin dependent diabetes mellitus
RK Sharma, Pralhad S Patki
January-March 2010, 1(1):45-51
DOI
:10.4103/0975-9476.59827
PMID
:21829301
Diabetes mellitus describes a metabolic disorder of multiple etiologies characterized by insulin resistance, relative insulin deficiency and hyperglycemia with disturbances of carbohydrate, fat and protein metabolism. The goal for treatment of diabetes is to prevent its acute manifestations and long-term microvascular and macrovascular complications. The present study was conducted to evaluate the efficacy and safety of an Ayurvedic formulation (GlucoCare Capsules) in non-insulin dependent diabetes mellitus. Fifty NIDDM patients of pitta-kapha prakriti attending the outpatient department of the Government Ayurvedic Medical College, Guwahati, Assam, India were included in the study, and randomly divided into 2 groups, GlucoCare and placebo. All received either GlucoCare or placebo in a dose of 2 capsules twice daily, before meals for 3 months. All 50 patients completed the study - no drop outs, withdrawals or patients lost to follow up. The GlucoCare group showed significant improvement in symptoms from the 2
nd
month till the end of the study. GlucoCare was well tolerated by all patients throughout the treatment period with no evidence of adverse effects. The study indicates clinical efficacy of GlucoCare Capsules in the management of NIDDM in those belonging to pitta-kapha prakriti. The formulation is well tolerated and appears safe in the dosage used.
[ABSTRACT]
[FULL TEXT]
[PDF]
[PubMed]
4,425
824
-
EXPERIMENTAL
Studies on Brahma rasayana in male swiss albino mice: Chromosomal aberrations and sperm abnormalities
KP Guruprasad, Roshan Mascarenhas, PM Gopinath, K Satyamoorthy
January-March 2010, 1(1):40-44
DOI
:10.4103/0975-9476.59826
PMID
:21829300
Ayurveda, the Indian holistic healthcare system encompasses traditional medicines with a principle of creating harmony and maintaining balance within the natural rhythms of the body. Rasayana is one of the branches of Ayurveda frequently used as rejuvenant therapy to overcome many discomforts and prevent diseases. It has been reported that rasayanas have immunomodulatory, antioxidant and antitumor functions. However, the genotoxic potential of many rasayanas remains to be evaluated. The present study was undertaken to assess the role of Brahma rasayana(BR) on genotoxicity
in vivo
in a mouse test system. The older mice (9 months) were orally fed with rasayana for 8 weeks. The treated groups showed no signs of dose-dependent toxicity at the dosage levels tested. The body weight loss/gain and feed consumption were unaffected at tested doses. Furthermore, sperm abnormalities and chromosomal aberrations were insignificant in the treatment group when compared to controls. However, there was a marginal increase in sperm count in the BR treated animals. These findings clearly indicate that there are no observed adverse genotoxic effects elicited by BR in experimental animals such as mice.
[ABSTRACT]
[FULL TEXT]
[PDF]
[PubMed]
3,217
760
-
Cyperus rotundus
, a substitute for
Aconitum heterophyllum
: Studies on the Ayurvedic concept of Abhava Pratinidhi Dravya (drug substitution)
Padma Venkatasubramanian, Subrahmanya K Kumar, Venugopalan S.N Nair
January-March 2010, 1(1):33-39
DOI
:10.4103/0975-9476.59825
PMID
:21829299
In the absence of a desired first choice medicinal herb, classical Ayurveda recommends use of a functionally similar substitute. Post 16th century Ayurvedic texts and lexicons give specific examples of possible substitutes. Here we report a preliminary study of one such Ayurvedic substitution pair:
Musta
(
Cyperus rotundus
L., Cyperaceae), a common weed, for the rare Himalayan species,
Ativisha
(
Aconitum heterophyllum
Wall. ex Royle; Ranunculaceae). The study's strategy was to use modern phytochemical and pharmacological methods to test the two herbs for biochemical and metabolic similarities and differences, and literary studies to compare their Ayurvedic properties, a novel trans-disciplinary approach. No previous scientific paper has compared the two herbs' bioactivities or chemical profiles. Despite being taxonomically unrelated, the first choice, but relatively unavailable (Abhava) plant,
A
.
heterophyllum
, and its substitute (Pratinidhi)
C
.
rotundus
, are not only similar in Ayurvedic pharmacology (Dravyaguna) profile, but also in phytochemical and anti-diarrheal properties. These observations indicate that Ayurveda may attach more importance to pharmacological properties of raw drugs than to their botanical classification. Further research into the nature of raw drugs named could open up new areas of medicinal plant classification, linking chemistry and bioactivity. Understanding the logic behind the Ayurvedic concept of
Abhava Pratinidhi Dravya
(drug substitution) could lead to new methods of identifying legitimate drug alternatives, and help solve industry's problems of crude drug shortage.
[ABSTRACT]
[FULL TEXT]
[PDF]
[PubMed]
3,049
739
-
REVIEW ARTICLE
Traditional medicine and genomics
Kalpana Joshi, Yogita Ghodke, Pooja Shintre
January-March 2010, 1(1):26-32
DOI
:10.4103/0975-9476.59824
PMID
:21829298
'Omics' developments in the form of genomics, proteomics and metabolomics have increased the impetus of traditional medicine research. Studies exploring the genomic, proteomic and metabolomic basis of human constitutional types based on Ayurveda and other systems of oriental medicine are becoming popular. Such studies remain important to developing better understanding of human variations and individual differences. Countries like India, Korea, China and Japan are investing in research on evidence-based traditional medicines and scientific validation of fundamental principles. This review provides an account of studies addressing relationships between traditional medicine and genomics.
[ABSTRACT]
[FULL TEXT]
[PDF]
[PubMed]
2,556
887
-
LIFE PROFILES
Padmashri P. K. Warrier, Arya Vaidya Sala, Kottakkal
GG Gangadharan
January-March 2010, 1(1):66-67
DOI
:10.4103/0975-9476.59831
PMID
:21829305
[FULL TEXT]
[PDF]
[PubMed]
2,967
351
-
EDITORIAL
J-AIM - A Renaissance for Ayurveda
Bhushan Patwardhan
January-March 2010, 1(1):1-2
DOI
:10.4103/0975-9476.59816
PMID
:21829290
[FULL TEXT]
[PDF]
[PubMed]
2,058
731
-
EDITORS«SQ» THOUGHT LEADERSHIP ARTICLE
Conceptual framework for new models of integrative medicine
Darshan Shankar
January-March 2010, 1(1):3-5
DOI
:10.4103/0975-9476.59817
PMID
:21829291
[FULL TEXT]
[PDF]
[PubMed]
1,766
655
-
DISCUSSION KERNEL
Standards of reporting Ayurvedic clinical trials - Is there a need?
Ashwini Mathur, Vivek Sankar
January-March 2010, 1(1):52-55
DOI
:10.4103/0975-9476.59828
PMID
:21829302
Reported lack of efficacy of Ayurvedic treatments in clinical trials is often not due to inefficacy of the treatment itself, but arises from inadequacies of trial design. This paper argues that trials of Ayurvedic interventions should exclusively use its multi-component, individualized and inherently holistic approach, and that general guidelines for rigorously reporting such clinical trials should be developed. Holistic Ayurvedic clinical trials, rigorously conducted and with high standards of reporting should translate into good clinical science, and may be expected to generate higher credibility for clinical studies of the Ayurvedic knowledge system.
[ABSTRACT]
[FULL TEXT]
[PDF]
[PubMed]
1,844
515
-
EDITORS«SQ» THOUGHT LEADERSHIP ARTICLE
An advocacy for Vaidya-Scientists in Ayurvedic research
Ashok D.B Vaidya
January-March 2010, 1(1):6-8
DOI
:10.4103/0975-9476.59818
PMID
:21829292
[FULL TEXT]
[PDF]
[PubMed]
1,701
554
-
PEDAGOGY
Understanding Ayurveda
Vaidya Dilip Gadgil
January-March 2010, 1(1):77-80
DOI
:10.4103/0975-9476.59836
PMID
:21829307
Ayurveda needs to achieve its full potential both in India and globally. This requires imparting to its students full appreciation of Ayurveda's power and strength, particularly proper understanding of the advantages of applying it to treat chronic and acute diseases. To this end, we explain the necessity of learning Sanskrit as a medium of study, and the advantages of learning the Texts in the traditional way, rather than relying on translations with all the loss of meaning and precision, which that entails. We emphasize the use of
Triskandhakosha
as a means to fully understand Ayurveda fundamental concepts and technical terms, so that all their shades of meaning are fully understood, and all their usages given in different places in the texts. Only by such methods can full appreciation of Ayurvedic wisdom be achieved, and the full depth and power of its knowledge be applied. Only then will its true status among systems of medicine come to be appreciated, either in India or more widely in the world as a whole.
[ABSTRACT]
[FULL TEXT]
[PDF]
[PubMed]
1,447
500
-
EDITORS«SQ» THOUGHT LEADERSHIP ARTICLE
Ayurveda and the battle against chronic disease: An opportunity for Ayurveda to go mainstream?
Alex Hankey
January-March 2010, 1(1):9-12
DOI
:10.4103/0975-9476.59819
PMID
:21829293
[FULL TEXT]
[PDF]
[PubMed]
1,452
477
-
GENERAL ARTICLES
Integrative medicine to tackle the problem of chronic diseases
Rustum Roy
January-March 2010, 1(1):18-21
DOI
:10.4103/0975-9476.59822
PMID
:21829296
This article summarizes important ways that integrative medicine can contribute to resolving the global health crisis with special reference to the US. Research using modern methods of analysis of cellular changes at the epigenetic level has shown that diet and lifestyle interventions greatly improve the state of patients' health. Estimates have been given that up to 75% of all US health costs can be saved by these methods, particularly if applied preventatively. It is thus vital that active steps are taken to implement such programs, to reduce costs to citizens and society alike, as well as to Government.
[ABSTRACT]
[FULL TEXT]
[PDF]
[PubMed]
1,518
335
-
BOOK REVIEWS
'Legacy of Vagbhata' by M. S. Valiathan
K Rajagopalan, G Geetha Krishnan
January-March 2010, 1(1):70-71
[FULL TEXT]
[PDF]
1,337
386
-
EDITORS«SQ» THOUGHT LEADERSHIP ARTICLE
Quality of ingredients used in Ayurvedic herbal preparations
GG Gangadharan
January-March 2010, 1(1):16-17
DOI
:10.4103/0975-9476.59821
PMID
:21829295
[FULL TEXT]
[PDF]
[PubMed]
1,043
434
-
BOOK REVIEWS
'Taking traditional knowledge to the market': The modern image of the Ayurvedic and Unani industry1980-2000 by Maarten Bode
DBA Narayana
January-March 2010, 1(1):72-73
[FULL TEXT]
[PDF]
1,156
305
-
LIFE PROFILES
Acharya D. S. Antarkar: A Vaidya with a vision
Rama Ashok Vaidya, Ashwinikumar Raut
January-March 2010, 1(1):63-65
DOI
:10.4103/0975-9476.59830
PMID
:21829304
[FULL TEXT]
[PDF]
[PubMed]
1,173
275
-
EDITORS«SQ» THOUGHT LEADERSHIP ARTICLE
Ayurveda and integrative medicine: Riding a tiger
Bhushan Patwardhan
January-March 2010, 1(1):13-15
DOI
:10.4103/0975-9476.59820
PMID
:21829294
[FULL TEXT]
[PDF]
[PubMed]
1,036
409
-
VIGNETTE
The mind of Ayurveda: A conversation with a legend - Raghavan Thirumulpad
S Jalaja
January-March 2010, 1(1):68-69
DOI
:10.4103/0975-9476.59832
PMID
:21829306
[FULL TEXT]
[PDF]
[PubMed]
1,069
323
-
EVENTS
Events
Alex Hankey
January-March 2010, 1(1):81-84
[FULL TEXT]
[PDF]
900
223
-
NEWS AND COMMENT
News and Comment
G Geetha Krishnan
January-March 2010, 1(1):74-76
[FULL TEXT]
[PDF]
901
163
-
GENERAL ARTICLES
Citizen's choice of preferred system of healthcare as a fundamental human right
Gemma Burford
January-March 2010, 1(1):22-25
DOI
:10.4103/0975-9476.59823
PMID
:21829297
Fundamental rights are preconditions for any human to act with sufficient freedom and to be allowed sufficient choice to realize their potential. The right to indigenous medicine must be recognized as a fundamental human right for indigenous peoples. In accordance with the principles of Evidence-Based Medicine, every citizen should be allowed to benefit from the placebo effect. It constitutes an essential aspect of treatment, which is rightfully theirs on the basis of payment for health care - regardless of whether the payment is made out of pocket, or from public finance. It then follows that, the right of citizens to access the medical system of their choice should be formally acknowledged. That choice should be regarded as a Fundamental Human Right, which should under no circumstance be denied them - not for reasons of scientific prejudice, nor commercial ambition.
[ABSTRACT]
[FULL TEXT]
[PDF]
[PubMed]
818
211
-
INITIATIVES
The inter-university initiative CAPTURED: Bridging worldviews, ways of learning and ways of knowing
Bertus Haverkort
January-March 2010, 1(1):56-62
DOI
:10.4103/0975-9476.59829
PMID
:21829303
[FULL TEXT]
[PDF]
[PubMed]
805
204
-
Feedback
Subscribe
Sitemap
|
What's New
|
Feedback
|
Disclaimer
© Journal of Ayurveda and Integrative Medicine (Published and printed with financial support from the Department of AYUSH, Ministry of Health and Family Welfare, Government of India.)
Published by
Medknow
Online since 1
st
February, 2010